tiprankstipranks

Debra Odink Insider Profile

4 Followers
Debra Odink, CTO at Anthera Pharmaceuticals, holds 21.75K shares in Anthera Pharmaceuticals (Ticker: ANTH).
tipranks
Debra Odink

Debra Odink
Anthera Pharmaceuticals (ANTH)
CTO

Ranked #68,912 out of 98,743 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-23.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$653
100.00%
A breakdown of Debra Odink's holdings

Insider Roles

Anthera Pharmaceuticals
(ANTH)
CTO
Roles that Debra Odink holds in companies

Most Profitable Insider Trade

Stock:
Anthera Pharmaceuticals
(ANTH)
Rating:Informative Buy
Date:Sep 24, 2010 - Sep 24, 2011
Return:+16.10%
The most profitable trade made by Debra Odink

Debra Odink's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Anthera Pharmaceuticals
Oct 13, 2015
CTO
Uninformative Sell
7.41K
$652.53
Success Rate for
ANTH
1 out of 2 profitable transactions on
ANTH
50%
Average Return for
ANTH
Average return per transaction on
ANTH
-23.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 06, 2012
Uninformative Buy
$0.00
-
$0.00
Mar 27, 2013
Uninformative Buy
$0.00
-
$0.00
Jul 02, 2010
Uninformative Buy
$0.00
-
$0.00
Jan 11, 2013
Uninformative Buy
$0.00
-
$0.00
Jan 02, 2015
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see Debra Odink's performance on stock

Debra Odink insider profile FAQ

What is the percentage of profitable transactions made by Debra Odink?
The percentage of profitable transactions made by Debra Odink is 50%.
    What is the average return per transaction made by Debra Odink?
    The average return per transaction made by Debra Odink is -23.30%.
      What stocks does Debra Odink hold?
      Debra Odink holds: ANTH stocks.
        What was Debra Odink’s latest transaction?
        Debra Odink latest transaction was an Uninformative Sell of $7.41K.
          What was Debra Odink's most profitable transaction?
          Debra Odink’s most profitable transaction was an Informative Buy of ANTH stock on September 24, 2010. The return on the trade was 16.10%.
            What is Debra Odink's role in Anthera Pharmaceuticals?
            Debra Odink's role in Anthera Pharmaceuticals is CTO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.